Home > Result Summaries: Compounds > ropinirole > Result Summary for 101468/190

Result Summary for 101468/190

Result Summary

Protocol ID:	101468/190
Clinical Study ID:	SKF-101468/190
Official Title:	A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS).
Phase:	Phase 3
Study Indications or Diseases:	Restless Legs Syndrome
Generic Name:	ropinirole
Trade/Product Name:	requip;requip
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Trenkwalder C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd A W, Tidswell P, Saletu-Zyhlarz G, Telstad W, Ferini-Strambi L, on behalf of the TREAT RLS 1 Study Group. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004; 75: 92–97